Marques, D. F. P., Rose, A. M. C., Monge, S., Mart. Association between influenza vaccination and severe outcomes in adults aged ≥ 65 years hospitalized with laboratory-confirmed influenza: a retrospective cohort study, I-MOVE hospital network, Europe,. Expert Review of Vaccines, 25(1)
Introduction
Older adults face an increased risk of influenza-related intensive care unit (ICU) admission and in-hospital death (IHD). Although vaccination reduces hospitalization, its effect on these outcomes remains uncertain. We estimated the association between influenza vaccination and both outcomes among adults aged?≥65?years hospitalized with laboratory-confirmed influenza.
Research design and methods
We conducted a retrospective cohort study using European I-MOVE hospital network data (2015/16–2024/25); vaccination was defined as vaccine receipt?≥14?days before symptom onset. We estimated pooled-season adjusted risk ratios (aRR) using Poisson regression adjusting for potential confounders. We calculated relative risk reduction (RRR) as (1?aRR)×100, overall and by age group (65–79, ≥80?years).
Results
After exclusions, 4,257 patients (five study sites, six seasons) were included. ICU admission occurred in 3% of vaccinated and 5% of unvaccinated patients; IHD occurred in 5% of both groups. RRR was 11% (95% CI: ?21–34) against ICU admission (65–79?years: ?4%; ≥80?years: 44%). RRR against IHD was 26% (95% CI: 3–43); 17% and 29% in each respective age group.
Conclusions
Vaccination showed little or no association with ICU admission, but was associated with a one-quarter reduction in IHD among hospitalized older adults, reinforcing its benefits against fatal in-hospital outcomes.
Older adults face an increased risk of influenza-related intensive care unit (ICU) admission and in-hospital death (IHD). Although vaccination reduces hospitalization, its effect on these outcomes remains uncertain. We estimated the association between influenza vaccination and both outcomes among adults aged?≥65?years hospitalized with laboratory-confirmed influenza.
Research design and methods
We conducted a retrospective cohort study using European I-MOVE hospital network data (2015/16–2024/25); vaccination was defined as vaccine receipt?≥14?days before symptom onset. We estimated pooled-season adjusted risk ratios (aRR) using Poisson regression adjusting for potential confounders. We calculated relative risk reduction (RRR) as (1?aRR)×100, overall and by age group (65–79, ≥80?years).
Results
After exclusions, 4,257 patients (five study sites, six seasons) were included. ICU admission occurred in 3% of vaccinated and 5% of unvaccinated patients; IHD occurred in 5% of both groups. RRR was 11% (95% CI: ?21–34) against ICU admission (65–79?years: ?4%; ≥80?years: 44%). RRR against IHD was 26% (95% CI: 3–43); 17% and 29% in each respective age group.
Conclusions
Vaccination showed little or no association with ICU admission, but was associated with a one-quarter reduction in IHD among hospitalized older adults, reinforcing its benefits against fatal in-hospital outcomes.
See Also:
Latest articles in those days:
- Avian Influenza Weekly Update # 1062: 18 September 2026 3 hours ago
- Effectiveness of the 2025-2026 seasonal influenza vaccine among U.S. veterans: an observational study 4 hours ago
- Streamlined CRISPR-based assays for detection and subtyping of H5 and H7 avian influenza 2 days ago
- Host-specific effects of a pandemic H1N1 M gene on canine H3N2 influenza virus replication and immune responses 2 days ago
- Rapid Decline of Nesting Peregrine Falcons in the San Francisco Bay Region of California Synchronous with an Outbreak of H5N1 Highly Pathogenic Avian Influenza 2 days ago
[Go Top] [Close Window]


